These results from a cross-disease post-mortem cohort strengthen the retina's possible role as a specific and sensitive source for biomarkers predicting typical AD, primary tauopathies, synucleinopathies, and cortical TDP-43 (as seen in FTLD-TDP). This evidence concerns the gene TARDBP and Alzheimer disease.